30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Bone Therapeutics Completes Enrollment for ALLOB Spinal Fusion Study -

Bone Therapeutics finished recruitment of 32 patients in the U.S. Phase IIA study of ALLOB® allogeneic bone-cell therapy in lumbar spinal fusion. Following 1-year follow-up, patient data is expected in mid-2019. (Bone Therapeutics SA, 2/19/18)